ADMA Biologics ADMA EBIT

EBIT at other companies

AbCellera Biologics Inc.ABCL

-$62.78M-26.6%

Lifecore Biomedical, Inc.LFCR

$2.57M—

AnaptysBio, Inc.ANAB

-$34.64M-25.8%

Absci CorporationABSI

-$30.85M-11.2%

Avalo TherapeuticsAVTX

-$31.52M-63.2%

Apogee Therapeutics, Inc.APGE

-$82.77M-31.2%

FAQ

What is ADMA Biologics's EBIT?

ADMA Biologics (ADMA) reported EBIT of $52.45M in Q2 2026.

How has ADMA Biologics's EBIT changed year-over-year?

ADMA Biologics's EBIT increased by 22.5% year-over-year, from $42.8M to $52.45M.

What is the long-term trend for ADMA Biologics's EBIT?

Over 4 years (2021 to 2025), ADMA Biologics's EBIT has grown at a 34.6% compound annual growth rate (CAGR), from -$58.37M to $191.44M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.